Unverified50% confidenceFactExact time
The model predictions of AI drug discovery companies must ultimately be validated through wet-lab experiments—synthesizing the predicted molecules and testing their activity and toxicity.
1
Sources
50%
Confidence
Long-term
Relevance
11/10/2026
First Seen
Sources
Related Entities
Related Claims
UnverifiedA reliable AI-assisted drug discovery study should disclose the model version, training data, and prediction methods, and conduct blinded validation in independent wet-lab experiments.78% similarUnverifiedA "hit" by an AI model on a GPCR target generally refers to the early screening or binding validation stage, and reaching a clinical candidate compound still requires drug-likeness optimization and experimental validation.73% similarUnverifiedWet-lab validation typically involves in vitro expression and protein purification, biochemical assays to confirm catalytic activity, structural biology methods to resolve the three-dimensional conformation, and validation of physiological function at the cellular or organismal level, a process that usually takes months to years.72% similarUnverifiedCombining AI predictions with experimental perturbations (such as CRISPR screening) is the key path to validating their biological significance.72% similarUnverifiedIn the drug discovery process, downstream validation steps typically include molecular property prediction (such as LogP, solubility, membrane permeability), ADMET assessment, synthetic feasibility analysis, and molecular docking and binding affinity estimation.71% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1157609API
curl https://kongchang.com/api/v1/knowledge/claims/1157609MCP
get_claim(id=1157609)